U.S. agrees to pay Pfizer and BioNTech $2 billion for 100 million doses of coronavirus vaccine
Under the agreement, the U.S. will get 100 million doses of the vaccine, if it works, and can acquire 500 million additional doses if needed.
Under the agreement, the U.S. will get 100 million doses of the vaccine, if it works, and can acquire 500 million additional doses if needed.
